Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Shumpei Yokota »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Shumpei Mori < Shumpei Yokota < Shun Kaneumi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000010 (2005) Shumpei Yokota [Japon] ; Takako Miyamae ; Tomoyuki Imagawa ; Shigeki Katakura ; Rumiko Kurosawa ; Masaaki MoriClinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.
000051 (2007) Shumpei Yokota[Biologic response modifiers for juvenile idiopathic arthritis].
000070 (2008) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
000075 (2008) Shumpei Yokota[Interleukin-6 as a pathogenic factor of systemic-onset juvenile idiopathic arthritis].
000090 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaImprovement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
000157 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaInterleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells.
000285 (2010) Shumpei Yokota [Japon] ; Tadamitsu KishimotoTocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis.
000364 (2011) Yutaka Inaba ; Remi Ozawa ; Tomoyuki Imagawa ; Masaaki Mori ; Yoshinori Hara ; Takako Miyamae ; Chie Aoki ; Tomoyuki Saito ; Shumpei YokotaRadiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
000394 (2011) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Syuji Takei ; Takuji Murata ; Minako Tomiita ; Yasuhiko Itoh ; Satoshi Fujikawa ; Masaaki MoriGuidance on using tocilizumab for juvenile idiopathic arthritis.
000403 (2012) Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu KishimotoSafety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
000537 (2012) Toshihiko Shinoki [Japon] ; Ryoki Hara ; Utako Kaneko ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shumpei YokotaSafety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
000620 (2013) Yutaka Inaba [Japon] ; Remi Ozawa ; Chie Aoki ; Tomoyuki Imagawa ; Masaaki Mori ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Saito ; Shumpei YokotaRadiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
000698 (2013) Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLong-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
000702 (2012) Shumpei Yokota ; Toshio Tanaka ; Tadamitsu KishimotoEfficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
000948 (2014) Takako Miyamae [Japon] ; Susumu Yokoya ; Hisashi Yamanaka ; Shumpei YokotaEffect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
000993 (2013) Tomomi Sato ; Tomo Nozawa ; Taichi Kanetaka ; Masako Kikuchi ; Nodoka Sakurai ; Kazuko Yamazaki ; Takahiro Momoi ; Yoshiyuki Namai ; Shumpei Yokota2 cases of HLA-B27-positive seronegative spondylarthritides in pediatric age treated with adalimumab.
000A59 (2014) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
000B01 (2014) Chie Aoki ; Yutaka Inaba [Japon] ; Hyonmin Choe ; Utako Kaneko ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Mari S. Oba ; Shumpei Yokota ; Tomoyuki SaitoDiscrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
000B20 (2015) Shumpei Yokota [Japon] ; Masako Kikuchi ; Tomo Nozawa ; Taichi Kanetaka ; Tomomi Sato ; Kazuko Yamazaki ; Nodoka Sakurai ; Ryoki Hara ; Masaaki MoriPathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
000B53 (2014) Takeshi Ikegawa ; Kazuko Yamazaki ; Kenichi Nishimura ; Taichi Kanetaka ; Masako Kikuchi ; Tomo Nozawa ; Ryouki Hara ; Tomomi Sato ; Nodoka Sakurai ; Shumpei Yokota[A case of severe systemic juvenile idiopathic arthritis introduced tocilizumab in early phase of the disease].
000D37 (2015) Shumpei Yokota [Japon] ; Yasuhiko Itoh ; Tomohiro Morio ; Naokata Sumitomo ; Kaori Daimaru ; Seiji MinotaMacrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Shumpei Yokota" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Shumpei Yokota" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Shumpei Yokota
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021